KATHLEEN TOON: Open Payments
NPI 1083251821 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,165 in 107 payments from 25 companies in 2025. Trend: 2023 $1,515 · 2024 $1,318 · 2025 $2,165
Food & beverage: $1,991Education: $174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $478 |
| AstraZeneca Pharmaceuticals LP | 13 | $270 |
| Daiichi Sankyo Inc. | 9 | $226 |
| Janssen Biotech, Inc. | 7 | $219 |
| Novartis Pharmaceuticals Corporation | 9 | $167 |
| Eisai Inc. | 4 | $85 |
| Incyte Corporation | 1 | $75 |
| BeOne Medicines USA, Inc. | 2 | $69 |
| PFIZER INC. | 4 | $68 |
| Merck Sharp & Dohme LLC | 4 | $64 |
Products named: EPKINLY, ENHERTU, RYBREVANT, IMFINZI, KISQALI, Lenvima, VENCLEXTA, BRUKINSA.
Industry payments across AR — which companies pay providers there.
